Extension of the clinical range of facioscapulohumeral dystrophy: Report of six cases

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 1, 2000, Pages 114-116

  Van Der Kooi, A J ^a   Rosenberg, N ^a   De Visser, M ^a   Visser, M C ^b   Van Den Berg Vos, R ^b   Wokke, J H J ^b   Bakker, E ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Facioscapulohumeral muscular dystrophy

Indexed keywords

ADULT; ARTICLE; BIOMECHANICS; CASE REPORT; CHROMOSOME 4; CLINICAL EXAMINATION; DISEASE CLASSIFICATION; DNA DETERMINATION; FACIAL EXPRESSION; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; FOOT; GASTROCNEMIUS MUSCLE; HUMAN; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; SHOULDER; THIGH;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 4; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENES, DOMINANT; HUMANS; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; NEUROLOGIC EXAMINATION;

EID: 0034125804     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.1.114     Document Type: Article

References (16)

1. Tawil R, Figlewicz DA, Griggs RC, et al. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 1998;43:279-82.
2. Padberg GW, Lunt PW, Koch M, et al. Facioscapulohumeral muscular dystrophy. In: Emery AEH, ed. Diagnostic criteria for neuromuscular disorders. 2nd ed. London: Royal Society of Medicine, 1997:9-15.
3. Wijmenga C, Frants RR, Brouwer OF, et al. Localisation of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990;336:651-3.
4. Wijmenga C, Hewitt JE, Sandkuijl LA, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992;2:26-30.
5. Upadhyaya M, Maynard J, Rogers MT, et al. Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD. J Med Genet 1997;34:476-9.
6. Orrell RW, Tawil R, Forrester J, et al. Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology 1999;52:1822-6.
7. Lemmerts RJ, Van der Maarel SM, Van Deutekom JC, et al. Inter- and intrachromosomal subtelomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Molec Genet 1998;7:1207-14.
8. Chung CS, Morton NE. Discrimination of genetic entities in muscular dystrophy. Am J Hum Genet 1959;11:339-59.
9. Padberg G. Facioscapulohumeral disease [thesis]. University of Leiden, The Netherlands, 1982.
10. Tyler FH, Stephens FE. Studies in disorders of muscle. II. Clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family. Ann Intern Med 1999; 32:640-60.
11. Patijn J. De ziekte van Landouzy-Dejerine [thesis]. University of Amsterdam, The Netherlands, 1983.
12. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain 1954;77:169-231.
13. Lunt PV, Jardine PE, Koch MC, et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Molecul Genet 1995;4:951-8.
14. Ricci E, Galluzzi G, Deidda G, et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 1999;45: 751-7.
15. Tawil R, Forrester J, Griggs RC, et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. Ann Neurol 1996;39:744-8.
16. Lunt PW, Jardine PE, Koch M, et al. Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy. Muscle Nerve 1995;(suppl 2):S103-9.